Yahoo Web Search

  1. Ad
    related to BRISTOL-MYERS SQUIBB COMPANY
  1. Coming into today, shares of the biopharmaceutical company had gained 4.24% in the past month. In that same time, the Medical sector gained 0.32%, while the S&P 500 gained 3.92%. Meanwhile ...

  2. Bristol-Myers Squibb Company BMY announced long-term pooled efficacy and safety results from the phase III CheckMate-017 and CheckMate-057 studies in patients with ...

  3. Novartis Announces New Data on Spondylitis Drug Cosentyx

    Zacks via Yahoo FinanceSep 17 15:05 PM

    Swiss pharma giant Novartis AG NVS announced positive new data from the ongoing PREVENT study on spondylitis drug, Cosentyx (secukinumab). PREVENT is an ongoing two-year randomized, double-blind ...

  4. Top Ranked Income Stocks to Buy for September 12th

    Zacks via Yahoo FinanceSep 12 11:59 AM

    Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 12th: Bristol-Myers Squibb Company (BMY): This biopharmaceutical ...

  5. Horizon (HZNP) Up 36.7% YTD: Pipeline Development in Focus

    Zacks via Yahoo FinanceSep 12 14:02 PM

    The company has been focusing on expanding its orphan drug business. This is evident from its long-range plan, wherein the orphan drug business is expected to constitute approximately ...

  6. The FDA assigns a Fast Track status to AstraZeneca's (AZN) Farxiga to reduce the risk of cardiovascular death or worsening of heart failure in adult patients with HFrEF and HFpEF.

  7. Roche (RHHBY) Reports Positive Data on Tecentriq & MS Drug

    Zacks via Yahoo FinanceSep 12 13:09 PM

    Roche's (RHHBY) immuno-oncology drug, Tecentriq, meets the primary goal in a late-stage study in NSCLC patients. Also, the company reports positive data on its MS drug in a phase III study.

  8. Renal Cell Carcinoma Space in Focus: Some Key Developments

    Zacks via Yahoo FinanceSep 13 13:36 PM

    In April 2019, the FDA had approved this combination for the same indication. Given its market potential, most pharma/biotech bigwigs are scurrying to grab a larger chunk of this pie. Evidently, the focus is on better and effective treatments.

  9. Could the Trade War be Bullish for Stocks?

    Zacks via Yahoo FinanceSep 11 16:05 PM

    Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. This week ...

  10. 2 Large-Cap Companies Declare Dividends

    GuruFocus.com via Yahoo FinanceSep 12 17:36 PM

    Shares of Bristol-Myers Squibb Co. (NYSE:BMY) rose 0.18% to $49.33 in extended trading on Wednesday after the drugmaker announced the quarterly dividend. On Nov. 1, it will ...

  1. Ads
    related to BRISTOL-MYERS SQUIBB COMPANY